Argis İlaç achieved high rankings in Turkishtime magazine’s 2020 R&D survey, as it had in 2018 and 2019.
We ranked tenth among all companies and fifth among pharmaceutical companies for the number of projects carried out at our R&D centre.
We continue our R&D activities.
